119-hres-1079119th Congress

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

Sponsored By: Representative Gottheimer, Josh [D-NJ-5]

Introduced

Summary

robust funding for research on Charcot‑Marie‑Tooth disease at the National Institute of Neurological Disorders and Stroke is the resolution's central call, urging stronger federal support for studying this inherited nerve disorder. It notes that CMT damages peripheral nerves, is usually inherited, includes many types such as CMT4B3, affects about 126,000 people in the United States and 2.6 million worldwide, and that federal funding for CMT research was lower in 2022 than in 2021.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Gottheimer, Josh [D-NJ-5]

NJ • D

Cosponsors

  • Rep. Bacon, Don [R-NE-2]

    NE • R

    Sponsored 2/25/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation